Laurus Labs Limited vs Natco Pharma Limited
A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and Natco Pharma Limited (NATCOPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Natco Pharma Limited leads LAURUSLABS vs NATCOPHARM on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation04
- Profitability22
- Growth02
- Size & financial health22
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
NATCOPHARM takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
NATCOPHARM takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
EvenScale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + []
- − ["Stock is trading at 20.99 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
- + ["Company has delivered good profit growth of 26.2% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 23.6%", "Company is almost debt free."]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.